CHRONIC GRANULOMATOUS DISEASE
Clinical trials for CHRONIC GRANULOMATOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRANULOMATOUS DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC GRANULOMATOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for CGD: stem cell transplant breakthrough trial
⭐️ CURE ⭐️ Recruiting nowThis study tests whether adding special drugs (IL-6 and IFN-gamma blockers) to the standard stem cell transplant process can help cure chronic granulomatous disease (CGD), a condition that makes people prone to severe infections. About 50 people aged 4 to 65 with CGD will receive…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ CURE ⭐️
Last updated May 22, 2026 14:05 UTC
-
MRNA boost may help CGD patients fight infections
Disease control Recruiting nowThis early-stage study tests whether giving patients with chronic granulomatous disease (CGD) their own white blood cells, corrected with mRNA, can temporarily help them fight infections. Up to 25 men aged 18-75 with a specific gene mutation will receive the treatment and be moni…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 26, 2026 04:05 UTC
-
Gene therapy offers hope for rare immune disease
Disease control Recruiting nowThis trial tests a gene therapy for chronic granulomatous disease (CGD), a rare condition where the immune system cannot fight certain infections. The therapy uses a modified virus to deliver a working copy of the defective gene into the patient's own blood stem cells. The goal i…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE
Phase: NA • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Could a stem cell transplant fix broken immune systems?
Disease control Recruiting nowThis study tests a stem cell transplant for people aged 5 to 40 with common variable immunodeficiency (CVID) or other immune regulation disorders. The goal is to replace faulty immune cells with healthy donor cells using a gentle chemotherapy and radiation preparation. While the …
Matched conditions: CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated May 19, 2026 11:47 UTC